Calcium channel antagonists in the modern era of coronary thrombolysis: Benefit or detriment?
Publication
, Journal Article
Foley, JA; Becker, RC
Published in: Cardiovascular Drugs and Therapy
1996
Calcium channel antagonists are among the world's most widely prescribed class of drugs and are used most often in patients with hypertension and coronary artery disease. However, in the recent past serious questions have been raised concerning their potentially detrimental effects. One area of considerable clinical importance that deserves close inspection is the role of calcium channel antagonists following coronary reperfusion. Specifically, is there benefit or detriment?.
Duke Scholars
Published In
Cardiovascular Drugs and Therapy
DOI
ISSN
0920-3206
Publication Date
1996
Volume
10
Issue
4
Start / End Page
403 / 407
Related Subject Headings
- Cardiovascular System & Hematology
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Foley, J. A., & Becker, R. C. (1996). Calcium channel antagonists in the modern era of coronary thrombolysis: Benefit or detriment? Cardiovascular Drugs and Therapy, 10(4), 403–407. https://doi.org/10.1007/BF00051103
Foley, J. A., and R. C. Becker. “Calcium channel antagonists in the modern era of coronary thrombolysis: Benefit or detriment?” Cardiovascular Drugs and Therapy 10, no. 4 (1996): 403–7. https://doi.org/10.1007/BF00051103.
Foley JA, Becker RC. Calcium channel antagonists in the modern era of coronary thrombolysis: Benefit or detriment? Cardiovascular Drugs and Therapy. 1996;10(4):403–7.
Foley, J. A., and R. C. Becker. “Calcium channel antagonists in the modern era of coronary thrombolysis: Benefit or detriment?” Cardiovascular Drugs and Therapy, vol. 10, no. 4, 1996, pp. 403–07. Scival, doi:10.1007/BF00051103.
Foley JA, Becker RC. Calcium channel antagonists in the modern era of coronary thrombolysis: Benefit or detriment? Cardiovascular Drugs and Therapy. 1996;10(4):403–407.
Published In
Cardiovascular Drugs and Therapy
DOI
ISSN
0920-3206
Publication Date
1996
Volume
10
Issue
4
Start / End Page
403 / 407
Related Subject Headings
- Cardiovascular System & Hematology
- 1115 Pharmacology and Pharmaceutical Sciences